Legal Opinion
Gregory v. Pronai Therapeutics Inc.
District Court, S.D. Illinois
Decided March 13, 2018No. 16 Civ. 8703 (PAE)PublishedCited by 23 opinions
1Opinion of the Court
PAUL A. ENGELMAYER, District Judge:
*381In this putative class action under the federal securities laws, lead plaintiffs Michael Gregory, Yeshan Jagroo, and Mindy Frost (collectively, "plaintiffs") claim that pharmaceutical company ProNAi Therapeutics Inc.1 ("ProNAi"), its CEO and President Nick Glover ("Glover"), and its CFO Sukhi Jagpal ("Jagpal") (together, "ProNAi" or "defendants") made false and misleading statements touting the prospects of PNT2258, ProNAi's sole drug candidate. These statements were made between July 15, 2015, the day ProNAi's initial public offering prospectus was…
2Cases cited70 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
65 more not listed; retrieve them via the Exa API.
3Cited by23 opinions
- Ok. Firefighters Pension And Retirement v. LexmarkDistrict Court, S.D. Illinois · 2019
- In re Neurotrope, Inc. Sec. Litig.District Court, S.D. Illinois · 2018
- Altimeo Asset Management v. Qihoo 360 Technology Co. Ltd.District Court, S.D. New York · 2020
- Avalanche IP, LLC v. FAM, LLCDistrict Court, D. Massachusetts · 2021
- Banerjee v. Zhangmen Education Inc.District Court, S.D. New York · 2023
18 more not listed; retrieve them via the Exa API.